(S)-N-(1-Amino-1-oxohexan-2-yl)-6-(4-methoxyphenyl)-2-oxohexanamide

ID: ALA3884194

Chembl Id: CHEMBL3884194

PubChem CID: 132819920

Max Phase: Preclinical

Molecular Formula: C19H28N2O4

Molecular Weight: 348.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCC[C@H](NC(=O)C(=O)CCCCc1ccc(OC)cc1)C(N)=O

Standard InChI:  InChI=1S/C19H28N2O4/c1-3-4-8-16(18(20)23)21-19(24)17(22)9-6-5-7-14-10-12-15(25-2)13-11-14/h10-13,16H,3-9H2,1-2H3,(H2,20,23)(H,21,24)/t16-/m0/s1

Standard InChI Key:  GMHHKLKBOXEOHM-INIZCTEOSA-N

Alternative Forms

  1. Parent:

    ALA3884194

    ---

Associated Targets(Human)

PLA2G5 Tchem Phospholipase A2 group V (238 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLA2G4A Tchem Cytosolic phospholipase A2 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pla2g1b Phospholipase A2 group 1B (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 348.44Molecular Weight (Monoisotopic): 348.2049AlogP: 2.14#Rotatable Bonds: 12
Polar Surface Area: 98.49Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.01CX Basic pKa: CX LogP: 3.14CX LogD: 3.14
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.45Np Likeness Score: 0.00

References

1. Smyrniotou A, Kokotou MG, Mouchlis VD, Barbayianni E, Kokotos G, Dennis EA, Constantinou-Kokotou V..  (2017)  2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A2 inhibitors.,  25  (3): [PMID:28034646] [10.1016/j.bmc.2016.12.007]

Source